SANA Sana Biotechnology, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 10, 2026
$2.89
· % 处于52周区间
· 高于低点
· 至高点
$2.6152周低点
$6.5552周高点
市值 (MRQ)
$865M
P/E
-3.0
EPS
$-0.96
SANA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$2.89
市值 (MRQ)
$865M
P/E
-3.0
EPS
$-0.96
ROE
-172.3%
52周区间
$3–$7
SANA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 Sana Biotechnology, Inc. - Common Stock 公司概况（来自维基百科）
行业板块Healthcare
行业Biotechnology
员工142
国家US
10年表现 收入、净利润、利润率和每股收益趋势
EPS$-0.962020-12-31 → 2025-12-31
自由现金流$-145M2021-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | SANA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | -3.05年均值 ≈-3.7 | ≈-3.7 | · | · | |
| 市净率 (MRQ) | 5.65年均值 ≈3.3 | ≈3.3 | 4.7 | 估值过高 | |
| 股价/自由现金流 (TTM) | -6.45年均值 ≈-4.9 | ≈-4.9 | · | · | |
| 市现率 (TTM) | -6.55年均值 ≈-5.3 | ≈-5.3 | · | · | |
| 市净率（有形资产） (MRQ) | 9.15年均值 ≈6.1 | ≈6.1 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | SANA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| ROA | -53.2%5年均值 ≈-42.0% | ≈-42.0% | -35.0% | 弱 | |
| ROE | -172.3%5年均值 ≈-90.7% | ≈-90.7% | -50.7% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | SANA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 1.45年均值 ≈3.7 | ≈3.7 | 6.4 | 低流动性 | |
| Quick Ratio (速动比率) | 1.85年均值 ≈3.5 | ≈3.5 | 4.6 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
资本效率 资产周转率、库存周转率、应收账款周转率
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-12.9%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 10, 2026 | $-0.22 | $-0.15 | -47.9% |
| 2026年3月31日 | 五月 13, 2026 | $-0.17 | $-0.17 | 1.7% |
| 2025年12月31日 | $-0.21 | $-0.14 | -55.0% | |
| 2025年9月30日 | $-0.16 | $-0.18 | 12.8% | |
| 2025年6月30日 | $-0.21 | $-0.21 | 0.47% | |
| 2025年3月31日 | $-0.21 | $-0.23 | 10.3% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $132M | $216M | $262M | $286M | $249M | $133M | |
| SG&A Expense | $44M | $64M | $73M | $72M | $50M | $28M | |
| Operating Expenses | $250M | $273M | $293M | $273M | $357M | $286M | |
| Operating Income | $-250M | $-273M | $-293M | $-273M | $-357M | $-286M | |
| Other Non-op | $2M | $-5M | $-52.0K | $-674.0K | $305.0K | $97.0K | |
| Pretax Income | · | · | · | · | $-356M | $-285M | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-244M | $-267M | $-283M | $-269M | $-356M | $-285M | |
| EPS (Basic) | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 | $-21.92 | |
| EPS (Diluted) | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 | $-21.92 | |
| Shares (Basic) | 253,234,000 | 230,891,000 | 194,541,000 | 188,344,000 | 166,433,000 | 13,014,000 | |
| Shares (Diluted) | 253,234,000 | 230,891,000 | 194,541,000 | 188,344,000 | 166,433,000 | 13,014,000 | |
| EBITDA | $-250M | $-273M | $-293M | $-273M | $-357M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $72M | $128M | $134M | $177M | $253M | $125M | |
| Short-term Investments | $67M | $25M | $72M | $247M | $298M | $253M | |
| Prepaid Expense | $6M | $4M | $4M | $14M | $7M | $6M | |
| Current Assets | $149M | $161M | $214M | $444M | $558M | $384M | |
| PP&E (Net) | $27M | $77M | $71M | $67M | $65M | $47M | |
| PP&E (Gross) | $82M | $131M | $112M | $101M | $84M | $55M | |
| Accum. Depreciation | $55M | $54M | $42M | $34M | $19M | $8M | |
| Goodwill | $141M | $141M | $141M | $141M | $141M | $141M | |
| Intangibles | $59M | $59M | $59M | $59M | $59M | $59M | |
| Other Non-current Assets | $3M | $5M | $6M | $5M | $5M | $190.0K | |
| Total Assets | $417M | $501M | $565M | $823M | $1.13B | $730M | |
| Accounts Payable | $2M | $5M | $4M | $3M | $2M | $2M | |
| Current Liabilities | $79M | $45M | $64M | $112M | $99M | $31M | |
| Capital Leases | $64M | $82M | $91M | $96M | $102M | $68M | |
| Other Non-current Liabilities | $11M | $10M | · | · | · | $540.0K | |
| Total Liabilities | $256M | $251M | $278M | $323M | $401M | $299M | |
| Common Stock | $27.0K | $22.0K | $20.0K | $19.0K | $18.0K | $2.0K | |
| Paid-in Capital | $2.01B | $1.86B | $1.63B | $1.56B | $1.52B | $8M | |
| Retained Earnings | $-1.85B | $-1.60B | $-1.34B | $-1.05B | $-785M | $-429M | |
| AOCI | $28.0K | $14.0K | $-60.0K | $-4M | $-1M | $30.0K | |
| Stockholders' Equity | $161M | $251M | $288M | $499M | $729M | $-421M | |
| Liabilities + Equity | $417M | $501M | $565M | $823M | $1.13B | $730M | |
| Shares Outstanding | 266,732,000 | 223,923,000 | 197,857,000 | 191,022,000 | 184,929,000 | 16,170,000 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $25M | $38M | $36M | $38M | $22M | $6M | |
| Amort. of Intangibles | $0 | $0 | $0 | $0 | $0 | · | |
| Operating Cash Flow | $-144M | $-223M | $-254M | $-290M | $-251M | $-138M | |
| CapEx | $938.0K | $33M | $20M | $21M | $30M | $24M | |
| Investing Cash Flow | $-40M | $17M | $172M | $211M | $-246M | $-253M | |
| Stock Issued | $126M | $181M | $27M | $4M | $5M | · | |
| Net Stock Activity | $126M | · | $5M | $601.0K | · | · | |
| Financing Cash Flow | $129M | $200M | $32M | $5M | $632M | $436M | |
| Net Change in Cash | $-55M | $-6M | $-50M | $-75M | $135M | $45M | |
| Free Cash Flow | $-145M | $-257M | $-274M | $-311M | $-281M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -53.2% | -50.0% | -40.8% | -27.6% | -38.3% | · | |
| ROE | -172.3% | -98.3% | -86.7% | -50.6% | -45.7% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 3.5 | 3.3 | 4.0 | 5.6 | · | |
| Quick Ratio | 1.8 | 3.4 | 3.2 | 3.8 | 5.6 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.60 | $1.12 | $1.45 | $2.61 | $3.94 | · | |
| Cash Flow / Share | $-0.57 | $-0.97 | $-1.30 | $-1.54 | · | · | |
| Cash / Share | $0.27 | $0.57 | $0.67 | $0.93 | $1.37 | · | |
| EPS (TTM) | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 | $-21.92 |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-244M | $-267M | $-283M | $-269M | $-356M | $-285M | |
| Market Cap | $1.09B | $365M | $807M | $755M | $2.86B | · | |
| P/E | -4.2 | -1.4 | -2.8 | -2.8 | -7.2 | · | |
| P/B | 6.7 | 1.5 | 2.8 | 1.5 | 3.9 | · | |
| P / Tangible Book | · | 7.2 | 9.2 | 2.5 | 5.4 | · | |
| P / Cash Flow | -7.5 | -1.6 | -3.2 | -2.6 | -11.4 | · | |
| P / FCF | -7.5 | -1.4 | -3.0 | -2.4 | -10.2 | · | |
| Earnings Yield | -23.6% | -71.2% | -35.8% | -36.2% | -13.8% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $31M | $29M | $35M | $30M | $30M | $37M | $45M | $53M | $61M | $56M | $66M | $73M | $67M | $77M | $73M | $73M | |
| SG&A Expense | $11M | $11M | $12M | $10M | $10M | $11M | $17M | $14M | $16M | $16M | $19M | $17M | $17M | $16M | $18M | $14M | |
| Operating Expenses | $65M | $49M | $61M | $44M | $95M | $51M | $51M | $62M | $49M | $111M | $2M | $116M | $84M | $86M | $73M | $32M | |
| Operating Income | $-65M | $-49M | $-61M | $-44M | $-95M | $-51M | $-51M | $-62M | $-49M | $-111M | $-2M | $-116M | $-84M | $-86M | $-73M | $-32M | |
| Other Non-op | $656.0K | $453.0K | $1M | $360.0K | $598.0K | $249.0K | $141.0K | $-742.0K | $-4M | $215.0K | $303.0K | $-84.0K | $-47.0K | $-106.0K | $-198.0K | $-102.0K | |
| Net Income | $-64M | $-47M | $-59M | $-42M | $-94M | $-49M | $-49M | $-60M | $-50M | $-107M | $984.0K | $-114M | $-82M | $-85M | $-72M | $-31M | |
| EPS (Basic) | $-0.22 | $-0.17 | $-0.20 | $-0.16 | $-0.39 | $-0.21 | $-0.21 | $-0.25 | $-0.21 | $-0.49 | $0.00 | $-0.59 | $-0.43 | $-0.45 | $-0.39 | $-0.17 | |
| EPS (Diluted) | $-0.22 | $-0.17 | $-0.20 | $-0.16 | $-0.39 | $-0.21 | $-0.21 | $-0.25 | $-0.21 | $-0.49 | $0.00 | $-0.59 | $-0.43 | $-0.45 | $-0.39 | $-0.17 | |
| Shares (Basic) | 295,667,000 | 276,856,000 | · | 260,494,000 | 238,409,000 | 237,578,000 | · | 235,412,000 | 234,440,000 | 217,290,000 | 196,978,000 | 192,540,000 | 191,228,000 | 189,303,000 | 187,626,000 | 185,955,000 | |
| Shares (Diluted) | 295,667,000 | 276,856,000 | · | 260,494,000 | 238,409,000 | 237,578,000 | · | 235,412,000 | 234,440,000 | 217,290,000 | 200,473,000 | 192,540,000 | 191,228,000 | 189,303,000 | 187,626,000 | 185,955,000 | |
| EBITDA | · | $-49M | · | $-44M | $-95M | $-51M | · | $-62M | $-49M | $-111M | $-2M | $-116M | $-84M | $-86M | $-73M | $-32M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $84M | $72M | $103M | $71M | $96M | $128M | $127M | $135M | $177M | $168M | $174M | $160M | $163M | $195M | $189M | |
| Short-term Investments | $103M | $17M | $67M | $50M | $1M | $9M | $25M | $72M | $117M | $134M | $100M | $152M | $189M | $322M | $290M | $324M | |
| Prepaid Expense | $6M | $6M | $6M | $5M | $6M | $4M | $4M | $7M | $8M | $6M | $7M | $7M | $15M | $8M | $10M | $11M | |
| Current Assets | $171M | $112M | $149M | $162M | $83M | $113M | $161M | $210M | $263M | $321M | $280M | $339M | $370M | $500M | $494M | $523M | |
| PP&E (Net) | $25M | $26M | $27M | $30M | $33M | $74M | $77M | $83M | $86M | $82M | $68M | $63M | $64M | $67M | $68M | $69M | |
| PP&E (Gross) | $85M | $83M | $82M | $84M | $86M | $131M | $131M | $136M | $135M | $127M | $116M | $105M | $103M | $98M | $94M | $91M | |
| Accum. Depreciation | $59M | $57M | $55M | $54M | $53M | $57M | $54M | $53M | $49M | $46M | $47M | $43M | $38M | $30M | $26M | $22M | |
| Goodwill | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | |
| Intangibles | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | |
| Other Non-current Assets | $552.0K | $563.0K | $3M | $3M | $3M | $4M | $5M | $6M | $6M | $7M | $6M | $7M | $5M | $5M | $5M | $5M | |
| Total Assets | $432M | $374M | $417M | $435M | $362M | $445M | $501M | $559M | $619M | $681M | $631M | $707M | $747M | $898M | $971M | $1.05B | |
| Accounts Payable | $1M | $2M | $2M | $2M | $2M | $989.0K | $5M | $3M | $4M | $6M | $10M | $3M | $2M | $4M | $3M | $5M | |
| Current Liabilities | $124M | $86M | $79M | $36M | $33M | $33M | $45M | $47M | $51M | $53M | $67M | $112M | $103M | $115M | $97M | $94M | |
| Capital Leases | $59M | $60M | $64M | $68M | $72M | $78M | $82M | $85M | $89M | $93M | $83M | $100M | $102M | $100M | $103M | $103M | |
| Other Non-current Liabilities | $9M | $10M | $11M | $8M | $8M | $9M | $10M | $7M | $7M | · | · | · | · | · | · | · | |
| Total Liabilities | $277M | $254M | $256M | $240M | $239M | $236M | $251M | $267M | $279M | $306M | $266M | $352M | $319M | $332M | $332M | $346M | |
| Common Stock | $30.0K | $27.0K | $27.0K | $26.0K | $23.0K | $23.0K | $22.0K | $22.0K | $22.0K | $22.0K | $20.0K | $20.0K | $19.0K | $19.0K | $19.0K | $19.0K | |
| Paid-in Capital | $2.11B | $2.02B | $2.01B | $1.99B | $1.87B | $1.86B | $1.86B | $1.85B | $1.84B | $1.82B | $1.62B | $1.61B | $1.57B | $1.55B | $1.54B | $1.52B | |
| Retained Earnings | $-1.96B | $-1.90B | $-1.85B | $-1.79B | $-1.75B | $-1.65B | $-1.60B | $-1.56B | $-1.50B | $-1.45B | $-1.25B | $-1.25B | $-1.14B | $-974M | $-889M | $-817M | |
| AOCI | $-66.0K | $-2.0K | $28.0K | $21.0K | $0 | $0 | $14.0K | $54.0K | $-19.0K | $-15.0K | $-202.0K | $-865.0K | $-2M | $-6M | $-6M | $-5M | |
| Stockholders' Equity | $155M | $119M | $161M | $195M | $123M | $209M | $251M | $292M | $340M | $375M | $366M | $355M | $428M | $566M | $640M | $702M | |
| Liabilities + Equity | $432M | $374M | $417M | $435M | $362M | $445M | $501M | $559M | $619M | $681M | $631M | $707M | $747M | $898M | $971M | $1.05B | |
| Shares Outstanding | 299,306,000 | 269,817,000 | 266,732,000 | 262,264,000 | 230,510,000 | 225,463,000 | 223,923,000 | 223,108,000 | 222,209,000 | 221,286,000 | 197,064,000 | 196,880,000 | 191,409,000 | 189,885,000 | 188,430,000 | 186,632,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $6M | $5M | $7M | $7M | $6M | $11M | $11M | $9M | $9M | $10M | $9M | $10M | $10M | $8M | |
| Operating Cash Flow | $-33M | $-37M | $-33M | $-29M | $-33M | $-49M | $-47M | $-52M | $-59M | $-66M | $-64M | $-59M | $-79M | $-65M | $-71M | $-78M | |
| CapEx | $2M | $288.0K | $873.0K | $41.0K | $-112.0K | $136.0K | $436.0K | $4M | $13M | $16M | $2M | $2M | $2M | $4M | $4M | $8M | |
| Investing Cash Flow | $-88M | $49M | $-16M | $-48M | $8M | $17M | $47M | $42M | $6M | $-77M | $51M | $43M | $63M | $32M | $78M | $13M | |
| Stock Issued | · | · | $17M | $109M | · | · | $0 | $-29.0K | · | · | $192.0K | $2M | $236.0K | $897.0K | $2M | $652.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $236.0K | · | · | · | |
| Financing Cash Flow | $94M | $-128.0K | $18M | $110M | $561.0K | $982.0K | $643.0K | $2M | $11M | $186M | $187.0K | $30M | $236.0K | $2M | $2M | $652.0K | |
| Net Change in Cash | $-27M | $12M | $-31M | $32M | $-25M | $-31M | $570.0K | $-8M | $-42M | $44M | $-12M | $13M | $-16M | $-31M | $8M | $-65M | |
| Free Cash Flow | · | $-38M | · | · | · | $-49M | · | · | · | $-81M | · | · | $-81M | · | · | $-85M |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -11.5% | · | -8.5% | -19.1% | -8.8% | · | -10.1% | -7.6% | -15.0% | 0.13% | -13.6% | -9.2% | -8.0% | -6.5% | -2.7% | |
| ROE | · | -28.8% | · | -17.3% | -40.6% | -16.9% | · | -18.2% | -14.5% | -26.8% | 0.21% | -22.9% | -14.5% | -12.2% | -9.4% | -4.0% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.3 | · | 4.6 | 2.5 | 3.4 | · | 4.5 | 5.2 | 6.1 | 4.2 | 3.0 | 3.6 | 4.4 | 5.1 | 5.6 | |
| Quick Ratio | · | 1.2 | · | 4.3 | 2.2 | 3.2 | · | 4.2 | 5.0 | 5.9 | 4.0 | 2.9 | 3.4 | 4.2 | 5.0 | 5.5 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.44 | · | $0.74 | $0.53 | $0.93 | · | $1.31 | $1.53 | $1.70 | $1.86 | $1.80 | $2.24 | $2.98 | $3.39 | $3.76 | |
| Cash Flow / Share | · | $-0.14 | · | · | · | $-0.20 | · | · | · | $-0.30 | · | · | $-0.41 | · | · | · | |
| Cash / Share | · | $0.31 | · | $0.39 | $0.31 | $0.43 | · | $0.57 | $0.61 | $0.80 | $0.85 | $0.88 | $0.84 | $0.86 | $1.03 | $1.01 | |
| EPS (TTM) | $-0.94 | $-0.92 | · | $-0.97 | $-1.06 | $-0.88 | · | $-1.39 | $-1.14 | $-1.52 | $-1.44 | $-1.89 | $-1.69 | $-1.62 | $-1.63 | $-1.15 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-212M | $-242M | · | $-234M | $-252M | $-209M | · | $-306M | $-245M | $-309M | $-276M | $-362M | $-320M | $-300M | $-298M | $-207M | |
| Market Cap | · | $777M | · | $931M | $629M | $379M | · | $928M | $1.21B | $2.21B | $763M | $1.17B | $626M | $1.14B | $1.21B | $1.54B | |
| P/E | -3.7 | -3.1 | · | -3.7 | -2.6 | -1.9 | · | -3.0 | -4.8 | -6.6 | -2.7 | -3.2 | -1.9 | -3.7 | -3.9 | -7.2 | |
| P/B | · | 6.5 | · | 4.8 | 5.1 | 1.8 | · | 3.2 | 3.6 | 5.9 | 2.1 | 3.3 | 1.5 | 2.0 | 1.9 | 2.2 | |
| P / Tangible Book | · | · | · | · | · | 40.9 | · | 10.0 | 8.7 | 12.6 | 4.6 | 7.6 | 2.7 | 3.1 | 2.8 | 3.1 | |
| P / Cash Flow | · | -20.8 | · | · | · | -7.8 | · | · | · | -33.7 | · | · | -7.9 | · | · | -19.8 | |
| Earnings Yield | -26.9% | -31.9% | · | -27.3% | -38.8% | -52.4% | · | -33.4% | -20.9% | -15.2% | -37.2% | -31.7% | -51.7% | -27.0% | -25.4% | -13.9% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 净收入 | $-244M | $-267M | $-283M | $-269M | $-356M |
| 稀释后每股收益 (EPS) | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 1.9 | 3.5 | 3.3 | 4.0 | 5.6 |
| 速动比率 | 1.8 | 3.4 | 3.2 | 3.8 | 5.6 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-145M | $-257M | $-274M | $-311M | $-281M |
机构持有人 (13F) 228 家申报者 · $688.7M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
228
持有价值
$688.7M
新仓位
33
已退出持仓
21
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 33 (+1 与上一季度对比) | 21 (-2 与上一季度对比) | 68 (0 与上一季度对比) | 66 (+8 与上一季度对比) | +20.8M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| FMR LLC | $130629007 | 37429515 | 18.97% | 股份 |
| Flagship Pioneering, LLC | $87256477 | 25001856 | 12.67% | 股份 |
| RA CAPITAL MANAGEMENT, L.P. | $65437500 | 18750000 | 9.50% | 股份 |
| BlackRock, Inc. | $58196354 | 16675173 | 8.45% | 股份 |
| VANGUARD GROUP INC | $42552645 | 10455195 | 6.18% | 股份 |
| STATE STREET CORP | $39098938 | 11203134 | 5.68% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $35662216 | 10218400 | 5.18% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $29230219 | 8375421 | 4.24% | 股份 |
| BANK OF AMERICA CORP /DE/ | $20062105 | 5748454 | 2.91% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $16329082 | 4677959 | 2.37% | 股份 |
| Marex Group Ltd | $13921959 | 3989100 | 2.02% | 股份 |
| MARSHALL WACE, LLP | $10230711 | 2931436 | 1.49% | 股份 |
| Alphabet Inc. | $9815625 | 2812500 | 1.43% | 股份 |
| GOLDMAN SACHS GROUP INC | $8264094 | 2367935 | 1.20% | 股份 |
| Integral Health Asset Management, LLC | $6980000 | 2000000 | 1.01% | 股份 |
| TORONTO DOMINION BANK | $6883610 | 1972381 | 1.00% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6567095 | 1881689 | 0.95% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $6521826 | 1868718 | 0.95% | 股份 |
| NORTHERN TRUST CORP | $5598252 | 1604084 | 0.81% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4813342 | 1379181 | 0.70% | 股份 |
| Woodline Partners LP | $4599583 | 1317932 | 0.67% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $4318655 | 1237437 | 0.63% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $4296539 | 1231100 | 0.62% | 股份 |
| MORGAN STANLEY | $3977839 | 1139782 | 0.58% | 股份 |
| UBS Group AG | $3704429 | 1061441 | 0.54% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $3361383 | 963147 | 0.49% | 股份 |
| Omega Fund Management, LLC | $2944688 | 843750 | 0.43% | 股份 |
| JPMORGAN CHASE & CO | $2681678 | 777298 | 0.39% | 股份 |
| Crestline Management, L.P. | $2637619 | 755736 | 0.38% | 股份 |
| ArrowMark Colorado Holdings LLC | $2391086 | 685125 | 0.35% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $2280725 | 653503 | 0.33% | 股份 |
| DEUTSCHE BANK AG\ | $2251353 | 645087 | 0.33% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $2229541 | 638837 | 0.32% | 股份 |
| Corient Private Wealth LP | $2192069 | 628100 | 0.32% | 股份 |
| Point72 Asset Management, L.P. | $2076868 | 595091 | 0.30% | 股份 |
| Invesco Ltd. | $1759875 | 504262 | 0.26% | 股份 |
| Bank of New York Mellon Corp | $1666621 | 477542 | 0.24% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1340450 | 384083 | 0.19% | 股份 |
| Nuveen, LLC | $1290329 | 369722 | 0.19% | 股份 |
| Swiss National Bank | $1214869 | 348100 | 0.18% | 股份 |
| BAKER BROS. ADVISORS LP | $1083586 | 310483 | 0.16% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $1028998 | 294842 | 0.15% | 股份 |
| CITIGROUP INC | $951109 | 272524 | 0.14% | 股份 |
| TWO SIGMA ADVISERS, LP | $902201 | 221671 | 0.13% | 股份 |
| XTX Topco Ltd | $790799 | 226590 | 0.11% | 股份 |
| RHUMBLINE ADVISERS | $779695 | 223412 | 0.11% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $694510 | 199000 | 0.10% | 买入期权 |
| Rafferty Asset Management, LLC | $686591 | 196731 | 0.10% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $674557 | 193283 | 0.10% | 股份 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $667313 | 231706 | 0.10% | 股份 |
公司内部人士 22 位内幕人士 · 10 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Steve Harr | President & CEO | 2026年3月7日 M | 7944251 | 0 | 0 | $0 |
| Brian Piper | EVP, Chief Financial Officer | 2026年2月17日 A | · | 0 | 0 | $0 |
| Nathan Hardy | EVP, Chief Financial Officer | 2024年3月7日 A | · | 0 | 0 | $0 |
| Dhavalkumar Dhirajlal Patel | EVP, Chief Scientific Officer | 2026年8月26日 M | 183352 | 0 | 0 | $0 |
| Susan D. Wyrick | SVP, Finance and Accounting and Principal Accounting Officer | 2026年3月7日 M | 196196 | 0 | 0 | $0 |
| Bernard J Cassidy | EVP & General Counsel | 2025年3月7日 M | 112990 | 0 | 0 | $0 |
| Christian Hordo | EVP, Chief Business Officer | 2024年3月7日 A | 867455 | 0 | 0 | $0 |
| Douglas E Williams | EVP & President, R&D | 2024年3月7日 A | · | 0 | 0 | $0 |
| James J. Macdonald | EVP & General Counsel | 2022年6月13日 M | 497396 | 0 | 0 | $0 |
| Sunil Agarwal | EVP, Head of Development & CMO | 2022年3月3日 A | 1550000 | 0 | 0 | $0 |
| Hans Edgar Bishop | 董事 | 2026年7月6日 A | 5854800 | 0 | 0 | $0 |
| Michelle Seitz | 董事 | 2026年6月4日 A | · | 0 | 0 | $0 |
| Alise Reicin | 董事 | 2026年6月4日 A | · | 0 | 0 | $0 |
| Robert L. Rosiello | 董事 | 2026年6月4日 A | · | 0 | 0 | $0 |
| Joshua H. Bilenker | 董事 | 2026年6月4日 A | 20000 | 0 | 0 | $0 |
| Richard Mulligan | 董事 | 2026年6月4日 A | 2698121 | 0 | 0 | $0 |
| Patrick Y Yang | 董事 | 2026年6月4日 A | 149250 | 0 | 0 | $0 |
| Robert Nelsen | 董事 | 2026年6月4日 A | 12446022 | 0 | 0 | $0 |
| Mary Agnes Wilderotter | 董事 | 2025年6月5日 A | 7106 | 0 | 0 | $0 |
| Douglas G. Cole | 董事 | 2024年6月6日 A | · | 0 | 0 | $0 |
| Geoffrey Von Maltzahn | 董事 | 2021年2月3日 A | 366122 | 0 | 0 | $0 |
| FMR LLC | 10% 所有者 | 2025年1月8日 S | 4541511 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 26 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.78% | 115976 NS | 2026年7月31日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.15% | 240493 NS | 2026年7月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.06% | 21172 SH | 2026年10月2日 | 每日 |
| PWS · Pacer Funds Trust | 0.04% | 3286 NS | 2026年7月31日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.04% | 384433 SH | 2026年10月2日 | 每日 |
| IBB · iShares Trust | 0.04% | 1388372 SH | 2026年9月11日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.04% | 196803 SH | 2026年8月19日 | 每日 |
| IWO · iShares Trust | 0.04% | 1718279 SH | 2026年9月11日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 1056163 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.02% | 4720089 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.02% | 87720 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 1941879 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.01% | 521984 SH | 2026年8月19日 | 每日 |
| ISCG · iShares Trust | 0.01% | 28058 SH | 2026年9月11日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 80330 NS | 2026年7月31日 | N-PORT |
| WSML · iShares Trust | 0.00% | 10383 SH | 2026年9月11日 | 每日 |
| TILT · FlexShares Trust | 0.00% | 22436 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 110952 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 256132 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 50195 SH | 2026年9月9日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.00% | 12291 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 6251644 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 13302 SH | 2026年8月19日 | 每日 |
| ISCB · iShares Trust | · | 8018 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 21821 SH | 2026年9月11日 | 每日 |
| SMLF · iShares Trust | · | 429504 SH | 2026年9月11日 | 每日 |
SANA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 15 位分析师
买入
中位数目标
$7.00
+142.2%
6 40.0%
强烈买入
7 46.7%
买入
2 13.3%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
7 位分析师 · 2026-09-30平均目标 $8.43 +191.6%
← 低于所有目标
当前价格 $2.89
最低$6.00
平均值$8.43
最高$12.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| OBX | · | · | · | · | · | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 10, 2026 申报